Neurodevelopmental Outcomes in the Drug-Exposed Premature Infant
Neurodevelopmental Outcomes in the Drug-Exposed Premature Infant is organized by The Pediatrix Center for Research, Education, Quality and Safety (CREQS).
Date & Location:
Friday, May 6, 2022, 8:00 AM - Monday, May 5, 2025, 11:59 PM
Overview:
The purpose of this educational activity is to enhance clinician knowledge in the ever-changing area of complications associated with Neonatology as well as promising new techniques and interventions for improving outcomes in this arena. This presentation will address the known risk of developmental impairment from sedative and pain control medications used in NICU patients.
ACCME Objectives:
• Discuss the available data on the long-term developmental impact of medications used in the NICU for pain control and sedation.
ANCC Learning Outcomes:
• Discuss the available data on the long-term developmental impact of medications used in the NICU for pain control and sedation.